These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 27074946)

  • 1. Baseline CD4/CD8 T-Cell Ratio Predicts Prompt Immune Restoration Upon cART Initiation.
    Bellissimo F; Pinzone MR; Celesia BM; Cacopardo B; Nunnari G
    Curr HIV Res; 2016; 14(6):491-496. PubMed ID: 27074946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD4+/CD8+ ratio restoration in long-term treated HIV-1-infected individuals.
    Caby F;
    AIDS; 2017 Jul; 31(12):1685-1695. PubMed ID: 28700392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of lifelong cumulative HIV viremia on long-term recovery of CD4+ cell count and CD4+/CD8+ ratio among patients on combination antiretroviral therapy.
    Seng R; Goujard C; Krastinova E; Miailhes P; Orr S; Molina JM; Saada M; Piroth L; Rouzioux C; Meyer L;
    AIDS; 2015 Mar; 29(5):595-607. PubMed ID: 25715104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characteristics and determinants of T-cell phenotype normalization in HIV-1-infected individuals receiving long-term antiretroviral therapy.
    Ndumbi P; Gillis J; Raboud J; Cooper C; Hogg RS; Montaner JS; Burchell AN; Loutfy MR; Machouf N; Klein MB; Tsoukas C;
    HIV Med; 2014 Mar; 15(3):153-64. PubMed ID: 24304582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral Regimens and CD4/CD8 Ratio Normalization in HIV-Infected Patients during the Initial Year of Treatment: A Cohort Study.
    De Salvador-Guillouët F; Sakarovitch C; Durant J; Risso K; Demonchy E; Roger PM; Fontas E
    PLoS One; 2015; 10(10):e0140519. PubMed ID: 26485149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course and Clinical Significance of CD8+ T-Cell Counts in a Large Cohort of HIV-Infected Individuals.
    Helleberg M; Kronborg G; Ullum H; Ryder LP; Obel N; Gerstoft J
    J Infect Dis; 2015 Jun; 211(11):1726-34. PubMed ID: 25489001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.
    Torti C; Prosperi M; Motta D; Digiambenedetto S; Maggiolo F; Paraninfo G; Ripamonti D; Cologni G; Fabbiani M; Caputo SL; Sighinolfi L; Ladisa N; El-Hamad I; Quiros-Roldan E; Frank I
    Clin Microbiol Infect; 2012 May; 18(5):449-58. PubMed ID: 21919996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD4+:CD8+ T Cell Ratio Normalization and the Development of AIDS Events in People with HIV Starting Antiretroviral Therapy.
    Okhai H; Vivancos-Gallego MJ; Hill T; Sabin CA
    AIDS Res Hum Retroviruses; 2020 Oct; 36(10):808-816. PubMed ID: 32664736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long terms trends in CD4+ cell counts, CD8+ cell counts, and the CD4+ :  CD8+ ratio.
    Hughes RA; May MT; Tilling K; Taylor N; Wittkop L; Reiss P; Gill J; Schommers P; Costagliola D; Guest JL; Lima VD; d'Arminio Monforte A; Smith C; Cavassini M; Saag M; Castilho JL; Sterne JAC
    AIDS; 2018 Jun; 32(10):1361-1367. PubMed ID: 29851663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors of a lower CD4/CD8 ratio in long term viral suppression HIV infected children.
    Guillén S; Prieto L; Jiménez de Ory S; González-Tomé MI; Rojo P; Navarro ML; Mellado MJ; Escosa L; Sainz T; Francisco L; Muñoz-Fernández MÁ; Ramos JT;
    PLoS One; 2019; 14(8):e0220552. PubMed ID: 31381604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.
    Leung V; Gillis J; Raboud J; Cooper C; Hogg RS; Loutfy MR; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Klein MB;
    PLoS One; 2013; 8(10):e77665. PubMed ID: 24204912
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune recovery in HIV-1 infected patients with sustained viral suppression under long-term antiretroviral therapy in Ethiopia.
    Wolday D; Legesse D; Kebede Y; Siraj DS; McBride JA; Striker R
    PLoS One; 2020; 15(10):e0240880. PubMed ID: 33091053
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of immune reconstitution and metabolic changes in women living with HIV: A real-world observational study.
    Wang X; Xiao J; Zhang L; Liu Y; Chen N; Deng M; Song C; Liu T; Zhang Y; Zhao H
    Chin Med J (Engl); 2023 Sep; 136(18):2168-2177. PubMed ID: 37580056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive role of CD4
    Li CX; Li YY; He LP; Kou J; Bai JS; Liu J; Tian B; Cao LJ; Wang KH; Kuang YQ
    BMC Immunol; 2019 Aug; 20(1):31. PubMed ID: 31455209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
    Bouteloup V; Sabin C; Mocroft A; Gras L; Pantazis N; Le Moing V; d'Arminio Monforte A; Mary-Krause M; Roca B; Miro JM; Battegay M; Brockmeyer N; Berenguer J; Morlat P; Obel N; De Wit S; Fätkenheuer G; Zangerle R; Ghosn J; Pérez-Hoyos S; Campbell M; Prins M; Chêne G; Meyer L; Dorrucci M; Torti C; Thiébaut R;
    HIV Med; 2017 Jan; 18(1):33-44. PubMed ID: 27625009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute HIV Infection and CD4/CD8 Ratio Normalization After Antiretroviral Therapy Initiation.
    Davy-Mendez T; Napravnik S; Zakharova O; Kuruc J; Gay C; Hicks CB; Mcgee KS; Eron JJ
    J Acquir Immune Defic Syndr; 2018 Dec; 79(4):510-518. PubMed ID: 30142143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.
    Hema MN; Ferry T; Dupon M; Cuzin L; Verdon R; Thiébaut R; Protopopescu C; Leport C; Raffi F; Le Moing V;
    PLoS One; 2016; 11(8):e0161594. PubMed ID: 27548257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of clinical progression among patients with immunological nonresponse despite virological suppression after combination antiretroviral treatment.
    Lapadula G; Cozzi-Lepri A; Marchetti G; Antinori A; Chiodera A; Nicastri E; Parruti G; Galli M; Gori A; Monforte Ad;
    AIDS; 2013 Mar; 27(5):769-79. PubMed ID: 23719349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.